Molina Healthcare (MOH)

• Market cap: $15.8B
• 1 day: -2.62%
• 5 days: 4.44%
• 1 month: -4.58%
• 3 months: -4.14%
• 6 months: -18.26%
• Year to date: -1.19%
• 1 year: -28.88%
• 5 years: 89.46%
• 10 years: 348.57%
• Sector: Financials
• Industry: Hospital & Medical Service Plans

About: Molina Healthcare Inc offers healthcare plans focused on Medicaid-related solutions for low-income families and individuals. Its health plans are operated by a network of subsidiaries, each of which is licensed as a health maintenance organization (HMO). It has four segments: Medicaid, Medicare, Marketplace and Others. The Medicaid, Medicare, and Marketplace segments represent the government-funded or sponsored programs under which it offers managed healthcare services. The Other segment, which is insignificant to its consolidated results of operations, includes long-term services and supports consultative services in Wisconsin. It generates majority revenue from Medicaid segment.

Employees: 18,000

Fund manager confidence

Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)

38% more first-time investments, than exits

New positions opened: 94 | Existing positions closed: 68

1% more funds holding

Funds holding: 602 [Q3] → 607 (+5) [Q4]

3% less repeat investments, than reductions

Existing positions increased: 222 | Existing positions reduced: 229

2.28% less ownership

Funds ownership: 94.94% [Q3] → 92.66% (-2.28%) [Q4]

19% less capital invested

Capital invested by funds: $19.2B [Q3] → $15.4B (-$3.73B) [Q4]

23% less call options, than puts

Call options by funds: $67M | Put options by funds: $87.2M

43% less funds holding in top 10

Funds holding in top 10: 7 [Q3] → 4 (-3) [Q4]

Research analyst outlook

5 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $305 7% upside
• Avg. target: $336 18% upside
• High target: $350 23% upside

5 analyst ratings

• positive: 1 20%
• neutral: 4 80%
• negative: 0 0%

Truist Securities David Macdonald 59% 1-year accuracy 57 / 96 met price target	20% upside $340	Buy Maintained	19 Feb 2025
Barclays Andrew Mok 38% 1-year accuracy 26 / 68 met price target	19% upside $339	Equal-Weight Maintained	7 Feb 2025
UBS Kevin Caliendo 50% 1-year accuracy 8 / 16 met price target	7% upside $305	Neutral Maintained	7 Feb 2025
Stephens & Co. Raj Kumar 33% 1-year accuracy 1 / 3 met price target	22% upside $345	Equal-Weight Reiterated	6 Feb 2025
JP Morgan John Stansel 0% 1-year accuracy 0 / 1 met price target	23% upside $350	Neutral Assumed	17 Dec 2024